A phase 4, single-arm study to evaluate the safety, antiviral activity and pharmacokinetics of tenofovir disoproxil fumarate in combination with emtricitabine in HIV-1 infected patients experiencing various degrees of renal impairment

Trial Profile

A phase 4, single-arm study to evaluate the safety, antiviral activity and pharmacokinetics of tenofovir disoproxil fumarate in combination with emtricitabine in HIV-1 infected patients experiencing various degrees of renal impairment

Completed
Phase of Trial: Phase IV

Latest Information Update: 11 Oct 2007

At a glance

  • Drugs Efavirenz; Emtricitabine; Emtricitabine/tenofovir disoproxil fumarate; Tenofovir disoproxil fumarate
  • Indications HIV-1 infections
  • Focus Therapeutic Use
  • Most Recent Events

    • 11 Oct 2007 The expected completion date for this trial is now 1 Jan 2007.
    • 02 Oct 2007 Status change from in progress to completed.
    • 14 Dec 2006 Status change
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top